Verastem, Inc. Quarterly Costs and Expenses in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Verastem, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2018 to Q3 2024.
  • Verastem, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $37M, a 73.8% increase year-over-year.
  • Verastem, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $125M, a 60.1% increase year-over-year.
  • Verastem, Inc. annual Costs and Expenses for 2023 was $92.1M, a 21.9% increase from 2022.
  • Verastem, Inc. annual Costs and Expenses for 2022 was $75.5M, a 19% increase from 2021.
  • Verastem, Inc. annual Costs and Expenses for 2021 was $63.5M, a 54% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $125M $37M +$15.7M +73.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $109M $28.3M +$7.99M +39.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $101M $28.1M +$8.72M +45.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $92.1M $31.1M +$14.3M +84.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $77.8M $21.3M +$3.6M +20.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $74.2M $20.3M -$1.11M -5.19% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $75.3M $19.3M -$232K -1.19% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $75.5M $16.8M -$210K -1.23% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $75.7M $17.7M +$2.86M +19.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $72.9M $21.4M +$4.96M +30.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $67.9M $19.6M +$4.46M +29.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $63.5M $17.1M -$204K -1.18% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 $63.7M $14.8M -$48.8M -76.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $112M $16.4M -$9.13M -35.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $122M $15.1M -$16.3M -51.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $138M $17.3M -$19.6M -53.2% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-18
Q3 2020 $158M $63.6M +$28.5M +81.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $129M $25.6M -$15.8M -38.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-02
Q1 2020 $145M $31.4M -$4.93M -13.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $150M $36.9M +$1.44M +4.06% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 $148M $35.1M -$1.94M -5.24% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-18
Q2 2019 $150M $41.4M +$13.2M +46.9% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-18
Q1 2019 $137M $36.3M +$15.6M +75% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-18
Q4 2018 $122M $35.5M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-11
Q3 2018 $37.1M Jul 1, 2018 Sep 30, 2018 10-K 2020-03-11
Q2 2018 $28.2M Apr 1, 2018 Jun 30, 2018 10-K 2020-03-11
Q1 2018 $20.8M Jan 1, 2018 Mar 31, 2018 10-K 2020-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.